Literature DB >> 22966299

Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.

Hidefumi Sasaki1, Yu Hikosaka, Osamu Kawano, Motoki Yano, Yoshitaka Fujii.   

Abstract

Large tumor suppressor (LATS) 1 and 2 are tumor suppressor genes implicated in the regulation of the cell cycle. The methylation statuses of the promoter regions of these genes were studied in Japanese lung cancers. The methylation statuses of the promoter regions of LATS1 and LATS2 were investigated by methylation-specific PCR. The findings were compared to clinicopathological features of lung cancer. Methylation-specific PCR showed that the LATS1 promoter region was hypermethylated in 95 out of 119 (79.8%) lung cancers. The methylation status of LATS1 was significantly associated with squamous histology (p=0.0267) and smoking status (never smoker vs. smoker; p=0.0399). LATS1-ummethylated patients harbored more EGFR mutations (p=0.0143). The LATS2 promoter region was hypermethylated in 160 out of 203 (78.8%) lung cancers. However, the methylation status had no association with the clinicopathological characteristics of the lung cancers cases. Both the LATS1 and LATS2 methylation statuses did not correlate with survival of lung cancer patients. Thus, the EGFR methylation status of the LATS genes has limited value in Japanese lung cancers.

Entities:  

Year:  2010        PMID: 22966299      PMCID: PMC3436364          DOI: 10.3892/ol_00000054

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis.

Authors:  X Yang; D M Li; W Chen; T Xu
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

2.  Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia.

Authors:  A Jiménez-Velasco; J Román-Gómez; X Agirre; M Barrios; G Navarro; I Vázquez; F Prósper; A Torres; A Heiniger
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

3.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

4.  EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.

Authors:  Hidefumi Sasaki; Katsuhiko Endo; Akimitsu Konishi; Minoru Takada; Masaaki Kawahara; Keiji Iuchi; Akihide Matsumura; Meinoshin Okumura; Hisaichi Tanaka; Tomoya Kawaguchi; Toshiki Shimizu; Hiroshi Takeuchi; Motoki Yano; Ichiro Fukai; Yoshitaka Fujii
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

5.  Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.

Authors:  Katsuhiko Endo; Akimitsu Konishi; Hidefumi Sasaki; Minoru Takada; Hisaichi Tanaka; Meinoshin Okumura; Masaaki Kawahara; Hironori Sugiura; Yoshiyuki Kuwabara; Ichiro Fukai; Akihide Matsumura; Motoki Yano; Yoshihiro Kobayashi; Kotaro Mizuno; Hiroshi Haneda; Eriko Suzuki; Keiji Iuchi; Yoshitaka Fujii
Journal:  Lung Cancer       Date:  2005-09-30       Impact factor: 5.705

6.  Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

Authors:  L Girard; S Zöchbauer-Müller; A K Virmani; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats/warts.

Authors:  N Yabuta; T Fujii; N G Copeland; D J Gilbert; N A Jenkins; H Nishiguchi; Y Endo; S Toji; H Tanaka; Y Nishimune; H Nojima
Journal:  Genomics       Date:  2000-01-15       Impact factor: 5.736

8.  Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).

Authors:  Hengning Ke; Jing Pei; Zhenya Ni; Hong Xia; Huilin Qi; Tishonna Woods; Ameeta Kelekar; Wufan Tao
Journal:  Exp Cell Res       Date:  2004-08-15       Impact factor: 3.905

9.  Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.

Authors:  John Peter McPherson; Laura Tamblyn; Andrew Elia; Eva Migon; Amro Shehabeldin; Elzbieta Matysiak-Zablocki; Bénédicte Lemmers; Leonardo Salmena; Anne Hakem; Jason Fish; Farah Kassam; Jeremy Squire; Benoit G Bruneau; M Prakash Hande; Razqallah Hakem
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

10.  LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma.

Authors:  Mojca Strazisar; Vid Mlakar; Damjan Glavac
Journal:  Lung Cancer       Date:  2008-11-12       Impact factor: 5.705

View more
  10 in total

1.  Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.

Authors:  Xu-Yong Lin; Xiu-Peng Zhang; Jun-Hua Wu; Xue-Shan Qiu; En-Hua Wang
Journal:  Tumour Biol       Date:  2014-03-29

2.  Contribution of LATS1 and LATS2 promoter methylation in OSCC development.

Authors:  Mohammad Ayoub Rigi Ladiz; Maryam Najafi; Dor Mohammad Kordi-Tamandani
Journal:  J Cell Commun Signal       Date:  2016-10-19       Impact factor: 5.782

3.  LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer.

Authors:  Saki Matsui; Naofumi Kagara; Chieko Mishima; Yasuto Naoi; Masafumi Shimoda; Atsushi Shimomura; Kenzo Shimazu; Seung Jin Kim; Shinzaburo Noguchi
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

Review 4.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

5.  Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.

Authors:  Showkat A Malik; Mosin S Khan; Majeed Dar; Mahboob Ul Hussain; Mohammad A Shah; Sheikh M Shafi; Syed Mudassar
Journal:  Pathol Oncol Res       Date:  2017-04-22       Impact factor: 3.201

6.  Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.

Authors:  Susan Y Luo; Ko-Yung Sit; Alan D L Sihoe; Wai-Sing Suen; Wing-Kuk Au; Ximing Tang; Edmond S K Ma; Wai-Kong Chan; Ignacio I Wistuba; John D Minna; George S W Tsao; David C L Lam
Journal:  Lung Cancer       Date:  2014-06-16       Impact factor: 5.705

7.  17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.

Authors:  Xiang-Yun Ye; Qing-Quan Luo; Yun-Hua Xu; Nai-Wang Tang; Xiao-Min Niu; Zi-Ming Li; Sheng-Ping Shen; Shun Lu; Zhi-Wei Chen
Journal:  J Cell Mol Med       Date:  2015-03       Impact factor: 5.310

8.  Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.

Authors:  Harsh Goel; Saloni Singhal; Runjhun Mathur; Saima Syeda; Rishi Kumar Gupta; Anshuman Kumar; Anju Shrivastava; Abhimanyu Kumar Jha
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

9.  m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression.

Authors:  Heng Zhang; Shao-Qiang Wang; Li Wang; Hang Lin; Jie-Bo Zhu; Ri Chen; Lin-Feng Li; Yuan-Da Cheng; Chao-Jun Duan; Chun-Fang Zhang
Journal:  Cell Death Dis       Date:  2022-07-28       Impact factor: 9.685

10.  Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.

Authors:  Maryam Najafi; Dor Mohammad Kordi-Tamandani; Mohammad Arish
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.